Skip to main content
Leiden University
Scholarly Publications
Home
Submit
About
Select Collection
All collections
Academic speeches
Dissertations
Faculty of Archaeology
Faculty of Governance and Global Affairs
Faculty of Humanities
Faculty of Science
Faculty of Social and Behavioural Sciences
Leiden Journals, Conference Proceedings and Books
Leiden Law School
Leiden University Press
Medicine / Leiden University Medical Centre (LUMC)
Research output UL
Search box
Your Search
Enabled Filters
(-)
= Meloni, G.
Sort Options
Date (year)
Author / Creator
Title
Refine Results
Resource Type
Article / Letter to editor
(8)
+
-
Availability
Open access
(1)
+
-
Metadata Only
(7)
+
-
Creation Date
2011
(2)
+
-
2014
(2)
+
-
Faculty
Leiden University Medical Center (LUMC)
(8)
+
-
Collection
Medicine / Leiden University Medical Centre (LUMC)
(8)
+
-
Author
Meloni, G.
(8)
+
-
Amadori, S.
(7)
+
-
Marie, J.P.
(7)
+
-
Muus, P.
(7)
+
-
Suciu, S.
(7)
+
-
Willemze, R.
(7)
+
-
Witte, T. de
(6)
+
-
Halkes, C.J.M.
(5)
+
-
Vignetti, M.
(5)
+
-
Lefrere, F.
(4)
+
-
Meert, L.
(4)
+
-
Thomas, X.
(4)
+
-
Venditti, A.
(4)
+
-
Baron, F.
(3)
+
-
Hagemeijer, A.
(3)
+
-
Karrasch, M.
(3)
+
-
Mancini, M.
(3)
+
-
Sica, S.
(3)
+
-
Specchia, G.
(3)
+
-
Beksac, M.
(2)
+
-
Berneman, Z.
(2)
+
-
Bron, D.
(2)
+
-
Camera, A.
(2)
+
-
Cantore, N.
(2)
+
-
Fabbiano, F.
(2)
+
-
Fazi, P.
(2)
+
-
Fillet, G.
(2)
+
-
Guimaraes, J.E.
(2)
+
-
Halkes, S.J.M.
(2)
+
-
Jansen, J.H.
(2)
+
-
Kicinski, M.
(2)
+
-
Labar, B.
(2)
+
-
Magro, D.
(2)
+
-
Mandelli, F.
(2)
+
-
Melillo, L.
(2)
+
-
Mistrik, M.
(2)
+
-
Nobile, F.
(2)
+
-
Sborgia, M.
(2)
+
-
Selleslag, D.
(2)
+
-
Stevens-Kroef, M.
(2)
+
-
Vrhovac, R.
(2)
+
-
Show more
Language
en
(8)
+
-
Search results
(1 - 8 of 8)
show grid
show list
save search
Impact of induction regimen and allogeneic hematopoietic cell transplantation on outcome in younger adults with acute myeloid leukemia with a monosomal karyotype
Cytogenetic clonal heterogeneity is not an independent prognosis factor in 15-60-year-old AML patients: results on 1291 patients included in the EORTC/GIMEMA AML-10 and AML-12 trials
Low-dose clofarabine in combination with a standard remission induction in patients aged 18-60 years with previously untreated intermediate and bad-risk acute myeloid leukemia or high-risk myelodysplastic syndrome: combined phase 1/11 results of the EORTC
Long-term follow-up of patients with acute myeloid leukemia surviving and free of disease recurrence for at least 2 years after autologous stem cell transplantation: A report from the Acute Leukemia Working Party of the European Society for Blood and Marr
Clofarabine in combination with a standard remission induction regimen (cytosine arabinoside and idarubicin) in patients with previously untreated intermediate and bad-risk acute myelogenous leukemia (AML) or high-risk myelodysplastic syndrome (HR-MDS): p
High-Dose Cytarabine in Induction Treatment Improves the Outcome of Adult Patients Younger Than Age 46 Years With Acute Myeloid Leukemia: Results of the EORTC-GIMEMA AML-12 Trial
High Dose (HD-AraC) Vs Standard Dose Cytosine Arabinoside (SD-AraC) During Induction and IL-2 Vs Observation After Consolidation/Autologous Stem Cell Transplantation in Patients with Acute Myelogenous Leukemia (AML): Final Report of the AML-12 Trial of EO
Clofarabine in Combination with a Standard Remission Induction Regimen (AraC and idarubicin) in Patients with Previously Untreated Intermediate and Bad Risk Acute Myelogenous Leukemia (AML) or High Risk Myelodysplasia (MDS): Phase I Results of An Ongoing
